|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/445 | |
| A61K 31/4545 | |||
| A61K 31/135 | |||
| A61K 31/381 | |||
| A61K 31/535 | |||
| A61K 31/55 | |||
| A61P 25/00 | |||
| A61K 45/06 |
| (11) | Number of the document | 3598975 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18306017.7 |
| Date of filing the European patent application | 2018-07-27 | |
| (97) | Date of publication of the European application | 2020-01-29 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
| (46) | Date of publication of the claims translation |
| (72) |
LIGNEAU, Xavier, FR
LANDAIS, Laurent, FR
PERRIN, David, FR
LECOMTE, Jeanne Marie, FR
SCHWARTZ, Jean Charles, FR
|
| (73) |
Bioprojet,
30 rue des Francs Bourgeois, 75003 Paris,
FR
|
| (54) | NOVEL COMBINATIONS OF A H3 ANTAGONIST AND A NORADRENALINE REUPTAKE INHIBITOR, AND THE THERAPEUTICAL USES THEREOF |
| NOVEL COMBINATIONS OF A H3 ANTAGONIST AND A NORADRENALINE REUPTAKE INHIBITOR, AND THE THERAPEUTICAL USES THEREOF |